Kintegral Advisory LLC Reduces Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Kintegral Advisory LLC lowered its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 4.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 805 shares of the medical instruments supplier’s stock after selling 37 shares during the period. Kintegral Advisory LLC’s holdings in Mettler-Toledo International were worth $985,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Huntington National Bank boosted its stake in shares of Mettler-Toledo International by 20.0% during the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 9 shares in the last quarter. Townsquare Capital LLC boosted its position in Mettler-Toledo International by 2.0% during the 3rd quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock valued at $693,000 after acquiring an additional 9 shares in the last quarter. M3 Advisory Group LLC boosted its position in Mettler-Toledo International by 5.8% during the 4th quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock valued at $202,000 after acquiring an additional 9 shares in the last quarter. Apollon Wealth Management LLC grew its holdings in shares of Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock worth $451,000 after acquiring an additional 9 shares during the period. Finally, HM Payson & Co. raised its position in shares of Mettler-Toledo International by 2.1% in the 3rd quarter. HM Payson & Co. now owns 541 shares of the medical instruments supplier’s stock worth $811,000 after acquiring an additional 11 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,285.67 on Friday. The company has a market capitalization of $26.90 billion, a price-to-earnings ratio of 31.72, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The company’s 50-day moving average is $1,285.56 and its 200 day moving average is $1,333.16.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, research analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the topic of several research reports. Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their target price for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Finally, Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,368.00.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.